NCT05649085

Brief Summary

The aim of the study is to prospectively evaluate the survival of JJGC Cobalt-Chromium (CoCr) prosthetic abutments in single-unit implant-supported prostheses, to confirm the long-term safety and performance of the devices.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
167

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 13, 2022

Completed
11 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

November 13, 2023

Status Verified

February 1, 2023

Enrollment Period

1.7 years

First QC Date

December 5, 2022

Last Update Submit

November 8, 2023

Conditions

Keywords

dental implantsdental prosthesis

Outcome Measures

Primary Outcomes (1)

  • Prosthesis survival arte

    Evaluation of the survival rate of implant-supported prostheses using CoCr prosthetic abutments.

    24 months after provisional prosthesis installation

Secondary Outcomes (6)

  • Implant survival rate

    24 months after provisional prosthesis installation

  • Implant success rate

    24 months after provisional prosthesis installation

  • Patient satisfaction

    24 months after provisional prosthesis installation

  • Clinician Satisfaction

    24 months after provisional prosthesis installation

  • Adverse events

    24 months after provisional prosthesis installation

  • +1 more secondary outcomes

Interventions

Cobalt-Chromium (CoCr) prosthetic abutments in single-unit implant-supported prostheses

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients over 18 years of age who were previously subjected to the installation of GM dental implants by JJGC, at the ILAPEO College, between 2018 and 2022, who are using a healing abutment or cover screw, will receive treatment for installation of single-unit prostheses, screwed or cemented, in the maxilla or mandible, using CoCr abutments, in digital or conventional flow. Patients will be followed up and evaluated at different times over a 2-year period.

You may qualify if:

  • Patients over 18 years of age
  • Patients who had GM dental implants from JJGC installed at the ILAPEO College, between 2018 and 2022
  • Patients who are using a healing abutment or cover screw and are able to install single-unit, screwed or cemented prostheses, in the maxilla or mandible, which require abutments with greater transmucosal height (due to reduced interocclusal height and/or bone loss)
  • Patients presenting antagonist teeth to the implant region

You may not qualify if:

  • Patients presenting contraindications according to the IFU (instructions for use)
  • Patients who require the installation of more than 3 single-unit prostheses with CoCr abutments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Latino Americano de Pesquisa e Ensino Odontológico (ILAPEO)

Curitiba, Brazil

RECRUITING

MeSH Terms

Conditions

AnodontiaProsthesis Failure

Condition Hierarchy (Ancestors)

Tooth AbnormalitiesStomatognathic System AbnormalitiesStomatognathic DiseasesTooth DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Waleska Caldas

    Neodent

    STUDY DIRECTOR

Central Study Contacts

Andrew Melenikiotis, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2022

First Posted

December 13, 2022

Study Start

November 1, 2023

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

November 13, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations